RT @hrkz1985: 人工呼吸器を必要としている重症COVID-19患者に対する抗凝固療法は予後を改善するかもしれない。観察研究。 https://t.co/BXSmAoTlfP
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with #COVID19 Ishan Paranjpe, BS, Valen https://t.co/QpbX5vyPOu https://t.co/8ouhgp9VnI
RT @nickmmark: Observational study of n=786 #COVID pt who received treatment dose #anticoagulation (AC) vs n=1987 who did not. AC associate…
RT @Yamamoto0509: 抗凝固療法がCOVID-19患者の死亡率を減らす? 入院中に機械的換気を必要とした395人の中では、抗凝固療法を受けていた患者の院内死亡率は29.1%で、抗凝固療法を受けていなかった患者の院内死亡率は62.7%だった。 https://t.c…
RT @Yamamoto0509: 抗凝固療法がCOVID-19患者の死亡率を減らす? 入院中に機械的換気を必要とした395人の中では、抗凝固療法を受けていた患者の院内死亡率は29.1%で、抗凝固療法を受けていなかった患者の院内死亡率は62.7%だった。 https://t.c…
RT @VPrasadMDMPH: Min 15 "I refuse to participate in a number of national and international studies or randomized trials, at that time..."…
Without RCTs and evidence, you could be harming people and never be any the wiser... As @RossCSchumacher discussed the other night (& common opinion), RCTs are the greatest advancement in the history of clinical medicine. Impt read 👇🏼
Wow. Good example for why both clinically and in research we must separate content expertise, evidence generation expertise, and evidence interpretation expertise. Certainly there can be remarkable overlap but not uncommon to find shockingly large divergen
RT @VPrasadMDMPH: Min 15 "I refuse to participate in a number of national and international studies or randomized trials, at that time..."…
RT @VPrasadMDMPH: Min 15 "I refuse to participate in a number of national and international studies or randomized trials, at that time..."…
RT @Yamamoto0509: 抗凝固療法がCOVID-19患者の死亡率を減らす? 入院中に機械的換気を必要とした395人の中では、抗凝固療法を受けていた患者の院内死亡率は29.1%で、抗凝固療法を受けていなかった患者の院内死亡率は62.7%だった。 https://t.c…
RT @VPrasadMDMPH: Min 15 "I refuse to participate in a number of national and international studies or randomized trials, at that time..."…
RT @Yamamoto0509: 抗凝固療法がCOVID-19患者の死亡率を減らす? 入院中に機械的換気を必要とした395人の中では、抗凝固療法を受けていた患者の院内死亡率は29.1%で、抗凝固療法を受けていなかった患者の院内死亡率は62.7%だった。 https://t.c…
RT @Yamamoto0509: 抗凝固療法がCOVID-19患者の死亡率を減らす? 入院中に機械的換気を必要とした395人の中では、抗凝固療法を受けていた患者の院内死亡率は29.1%で、抗凝固療法を受けていなかった患者の院内死亡率は62.7%だった。 https://t.c…
RT @Yamamoto0509: 抗凝固療法がCOVID-19患者の死亡率を減らす? 入院中に機械的換気を必要とした395人の中では、抗凝固療法を受けていた患者の院内死亡率は29.1%で、抗凝固療法を受けていなかった患者の院内死亡率は62.7%だった。 https://t.c…
RT @Yamamoto0509: 抗凝固療法がCOVID-19患者の死亡率を減らす? 入院中に機械的換気を必要とした395人の中では、抗凝固療法を受けていた患者の院内死亡率は29.1%で、抗凝固療法を受けていなかった患者の院内死亡率は62.7%だった。 https://t.c…
抗凝固療法がCOVID-19患者の死亡率を減らす? 入院中に機械的換気を必要とした395人の中では、抗凝固療法を受けていた患者の院内死亡率は29.1%で、抗凝固療法を受けていなかった患者の院内死亡率は62.7%だった。 https://t.co/X0qr0Fx4RN
The key findings from the observational study are in the screen shot. Patients given AC seemed to do better. Here is the link to the research letter in JACC https://t.co/eXCkLhlb8i https://t.co/O4GNoupP3i
RT @VPrasadMDMPH: Min 15 "I refuse to participate in a number of national and international studies or randomized trials, at that time..."…
RT @VPrasadMDMPH: Min 15 "I refuse to participate in a number of national and international studies or randomized trials, at that time..."…
RT @VPrasadMDMPH: Min 15 "I refuse to participate in a number of national and international studies or randomized trials, at that time..."…
😉
RT @VPrasadMDMPH: Min 15 "I refuse to participate in a number of national and international studies or randomized trials, at that time..."…
RT @VPrasadMDMPH: Min 15 "I refuse to participate in a number of national and international studies or randomized trials, at that time..."…
RT @VPrasadMDMPH: Min 15 "I refuse to participate in a number of national and international studies or randomized trials, at that time..."…
Min 15 "I refuse to participate in a number of national and international studies or randomized trials, at that time..." WOW! Folks often ask me y do doctors treat 5000 people in a giant, uncontrolled experiment without doing simple RCTs? [thread] https:
@VPrasadMDMPH @zahifayad @ParanjpeIshan @raj_mehta @drjohnm We then thought it appropriate to analyze this and present the results in the context of limitations after undergoing several internal rounds of vetting. It might be illuminating to listen to Dr.
@raj_mehta @VPrasadMDMPH @drjohnm 2. We tried to present our data as preliminary in a short research letter format and intend to analyze a larger number of patients who have completed their hospital course with less censoring. Dr. Fuster discusses this in
Our very own, @girish_nadkarni, analyzed crucial work that informs the use of therapeutic anticoagulation in #Covid19 from new research published in @JACCjournal. #JACC @IcahnMountSinai @MountSinaiNYC #covid https://t.co/EuNMJdu1lB https://t.co/BJJX7OCyi4
RT @UNMC_DrKhan: #NewSARS Treatment - Anticoagulation Observational study at Mt. Sinai as part of accumulating data from autopsy and parth…
RT @pat_pato_g: Hace semanas ya se decía.Anti coagulación y antinflamación precoz podría mejorar pronóstico en infección covid.vamos tenien…
RT @girish_nadkarni: Dr. Valentin Fuster breaks down our study and future steps. https://t.co/OeNeoDhN0M @zahifayad @dranulala @ParanjpeIsh…
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/UXi8bgzFih
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/mQMhnu1U6O
RT @UNMC_DrKhan: #NewSARS Treatment - Anticoagulation Observational study at Mt. Sinai as part of accumulating data from autopsy and parth…
RT @UNMC_DrKhan: #NewSARS Treatment - Anticoagulation Observational study at Mt. Sinai as part of accumulating data from autopsy and parth…
RT @UNMC_DrKhan: #NewSARS Treatment - Anticoagulation Observational study at Mt. Sinai as part of accumulating data from autopsy and parth…
RT @UNMC_DrKhan: #NewSARS Treatment - Anticoagulation Observational study at Mt. Sinai as part of accumulating data from autopsy and parth…
@TFORDCOVID19 @PremnathV6 @ProfBhargava @ICMRDELHI @MoHFW_INDIA
RT @UNMC_DrKhan: #NewSARS Treatment - Anticoagulation Observational study at Mt. Sinai as part of accumulating data from autopsy and parth…
RT @UNMC_DrKhan: #NewSARS Treatment - Anticoagulation Observational study at Mt. Sinai as part of accumulating data from autopsy and parth…
#NewSARS Treatment - Anticoagulation Observational study at Mt. Sinai as part of accumulating data from autopsy and parthenogenesis studies that implicate the coagulation system in mortality. https://t.co/ZueAybMKd1
@JJcolemanMD From clinicians standpoint, it’s getting a lot of attention. Most hospitals adopted protocols for higher dose of prophylaxis with daily bedside lower ext US, and others have protocols for empiric therapeutic anticoagulation based on risks, d d
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/3VygSodtHG a very important step forward
Hace semanas ya se decía.Anti coagulación y antinflamación precoz podría mejorar pronóstico en infección covid.vamos teniendo algo de evidencia sobre lo primero. Veremos q más aprendemos con el tiempo.parece q la patología cv gana puntos. Muxo por venir..h
RT @JACCJournals: New research published in #JACC from Journal Editor-in-Chief Dr. Valentin Fuster and team @IcahnMountSinai finds #cvCoag…
RT @influenzer3: ただし、入院期間が中央値5日と短く、抗凝固療法も経口、皮下、経静脈投与もすべてまとめて集計しており、薬物も提示されていません。 良く分からないので、しっかりとデザインされたRCTでの検証が必要かと。 https://t.co/uipJrgv46A
RT @girish_nadkarni: Dr. Valentin Fuster breaks down our study and future steps. https://t.co/OeNeoDhN0M @zahifayad @dranulala @ParanjpeIsh…
RT @Ron_George: Association of Treatment Dose #Anticoagulation with In-Hospital Survival Among Hospitalized Patients with #COVID19 https://…
RT @girish_nadkarni: Dr. Valentin Fuster breaks down our study and future steps. https://t.co/OeNeoDhN0M @zahifayad @dranulala @ParanjpeIsh…
RT @girish_nadkarni: Dr. Valentin Fuster breaks down our study and future steps. https://t.co/OeNeoDhN0M @zahifayad @dranulala @ParanjpeIsh…
Association of Treatment Dose #Anticoagulation with In-Hospital Survival Among Hospitalized Patients with #COVID19 https://t.co/tjnml6wMzO @dranulala @ParanjpeIshan @Adam_Russak @girish_nadkarni @BenGlicksberg @emiliabagiella @zahifayad @JACCJournals http
RT @girish_nadkarni: Dr. Valentin Fuster breaks down our study and future steps. https://t.co/OeNeoDhN0M @zahifayad @dranulala @ParanjpeIsh…
RT @mjvlewis: Importance of VTE assessments in COVID-19 cases @ManjeetShehmar @vbriaz @AnthonyJeffrin @drshelley @LorraineMosele4
RT @ACCinTouch: Listen to Dr. Fuster’s #JACC podcast for an in-depth explanation and commentary on the recently accepted research retter fr…
RT @sanchak74: This is good proof that mechanical ventilation induces coagulation (see right graph) as my theory suggests... Anti-coagulat…
RT @girish_nadkarni: Dr. Valentin Fuster breaks down our study and future steps. https://t.co/OeNeoDhN0M @zahifayad @dranulala @ParanjpeIsh…
Dr. Valentin Fuster breaks down our study and future steps. https://t.co/OeNeoDhN0M @zahifayad @dranulala @ParanjpeIshan @Adam_Russak @BenGlicksberg @aw_charney @emiliabagiella
RT @JeffCampsenMD: Mortality was decreased from 62% to 29% in ventilated patients. Association of Treatment Dose Anticoagulation with In-Ho…
Mortality was decreased from 62% to 29% in ventilated patients. Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/4yRzrWVB9c #COVID19 @UofUHealth
RT @influenzer3: ただし、入院期間が中央値5日と短く、抗凝固療法も経口、皮下、経静脈投与もすべてまとめて集計しており、薬物も提示されていません。 良く分からないので、しっかりとデザインされたRCTでの検証が必要かと。 https://t.co/uipJrgv46A
RT @GermHunterMD: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 In th…
Très bonnes explications !
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 | JACC: Journal of the American College of Cardiology https://t.co/bgFIMiSn5Z
RT @GermHunterMD: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 In th…
RT @GermHunterMD: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 In th…
RT @Noboru_Hagino: この論文に加えて、僕は、今のところ抗凝固は「DOACを使わない方がよい」、もっと積極的に「初期の抗凝固はunfractionated heparinがよい」と推測しています。 https://t.co/E7tsfnIajG
Importance of VTE assessments in COVID-19 cases @ManjeetShehmar @vbriaz @AnthonyJeffrin @drshelley @LorraineMosele4
RT @JACCJournals: Do you have questions about the recent #JACC Research Letter on #cvCoag and survival in hospitalized #COVID19 patients? D…
RT @JACCJournals: Do you have questions about the recent #JACC Research Letter on #cvCoag and survival in hospitalized #COVID19 patients? D…
RT @GermHunterMD: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 In th…
RT @ACCinTouch: Listen to Dr. Fuster’s #JACC podcast for an in-depth explanation and commentary on the recently accepted research retter fr…
RT @GermHunterMD: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 In th…
RT @ACCinTouch: Listen to Dr. Fuster’s #JACC podcast for an in-depth explanation and commentary on the recently accepted research retter fr…
RT @GermHunterMD: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 In th…
RT @GermHunterMD: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 In th…
RT @GermHunterMD: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 In th…
RT @GermHunterMD: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 In th…
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 In this retrospective cohort study, anticoagulation was associated with survival in ventilated patients (but not others) with COVID19 https
Listen to Dr. Fuster’s #JACC podcast for an in-depth explanation and commentary on the recently accepted research retter from @IcahnMountSinai on #cvCoag and survival in hospitalized #COVID19 patients. https://t.co/dGXZi29TD0 https://t.co/W68uVgeOLC
RT @JACCJournals: Do you have questions about the recent #JACC Research Letter on #cvCoag and survival in hospitalized #COVID19 patients? D…
Eksempler jeg har lagt merke til de siste dagene er for eksempel at pasientene lever en median 6 dager lengre på behandling med antikoagulerende (som i snitt blei gitt 2 dager etter innleggelse) 10/ https://t.co/bcfhWUAUI6
@CardioAcademic @cardioimagenmx
RT @JACCJournals: Do you have questions about the recent #JACC Research Letter on #cvCoag and survival in hospitalized #COVID19 patients? D…
Do you have questions about the recent #JACC Research Letter on #cvCoag and survival in hospitalized #COVID19 patients? Dr. Valentin Fuster provides in-depth explanation and commentary in a new podcast. 🎧 Listen here: https://t.co/xDAOkHiIjO https://t.co/
RT @influenzer3: ただし、入院期間が中央値5日と短く、抗凝固療法も経口、皮下、経静脈投与もすべてまとめて集計しており、薬物も提示されていません。 良く分からないので、しっかりとデザインされたRCTでの検証が必要かと。 https://t.co/uipJrgv46A
RT @sanchak74: This is good proof that mechanical ventilation induces coagulation (see right graph) as my theory suggests... Anti-coagulat…
RT @sanchak74: This is good proof that mechanical ventilation induces coagulation (see right graph) as my theory suggests... Anti-coagulat…
@CastlDalmunzie @MaaloufMD @SABOURETCardio @fischman_david @gina_lundberg @VietHeartPA @saia_francesco @DocSavageTJU @SilCastelletti @cpgale3 we are certainly seeing a lot of VTE and the 🇺🇸Mount Sinai registry would suggest that anti coagulants are benefic
RT @sanchak74: This is good proof that mechanical ventilation induces coagulation (see right graph) as my theory suggests... Anti-coagulat…
This is good proof that mechanical ventilation induces coagulation (see right graph) as my theory suggests... Anti-coagulation helps - and survival drops with ventilation https://t.co/fOFFpGktjW https://t.co/DUbAI6bcYI
Pacient s preventivní koagulací při Covid19. Asi to nebude ideální volba.
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 https://t.co/0mLvIADIP0 @MiguelNicolelis
RT @FZores: On va donc parler de cette étude. Ce sera moins un fil sur le résultat et la COVID qu'un fil de LCA (lecture critique d'articl…
RT @EricBillyFR: Pour ceux qui veulent pousser la compréhension de l’analyse d’une étude clinique, de la complexité et de la nécessité d’i…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…
RT @drjohnm: PSA for COVID19 Rx Don’t use flawed observational data to start giving potent anticoagulation to sick pts with COVID19. Even…